Fingerprint
Dive into the research topics where Katsuyuki Hotta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study
Kuribayashi, T., Makimoto, G., Ohashi, K., Tomida, S., Inoue, H., Yokoyama, T., Kuyama, S., Kato, Y., Kudo, K., Horita, N., Kayatani, H., Inoue, M., Sugimoto, K., Ninomiya, K., Maeda, Y., Togashi, Y. & Hotta, K., Jan 2026, In: Cancer Research Communications. 6, 2, p. 284-293 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Prompt Diagnosis of Ascites and Dramatic Effect of Alectinib for Advanced Lung Adenocarcinoma Harboring EML4-ALK Fusion
Baba, T., Inoue, H., Matsuoka, H., Kyakuno, M., Yoshinaga, Y., Takeguchi, T., Fujiwara, M., Yamada, K., Nakamura, E., Morita, A., Hara, N., Ninomiya, K., Higo, H., Fujii, M., Ichihara, E., Rai, K., Ohashi, K., Hotta, K., Tabata, M. & Maeda, Y. & 2 others, , Dec 1 2025, In: Internal Medicine. 64, 23, p. 3413-3418 6 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Association of the expression of 5-FU biomarkers with aging and prognosis in elderly patients with lung cancer treated with S-1 adjuvant chemotherapy: Follow-up results of the Setouchi Lung Cancer Group Study 1201
Soh, J., Yamamoto, H., Okumura, N., Suzuki, H., Nakata, M., Fujiwara, T., Gemba, K., Sano, I., Fujinaga, T., Kataoka, M., Terasaki, Y., Fujimoto, N., Kataoka, K., Kosaka, S., Yamashita, M., Inokawa, H., Inoue, M., Nakamura, H., Yamashita, Y. & Takahashi, Y. & 10 others, , 2025, In: Molecular and Clinical Oncology. 23, 3, p. 1-11 11 p., 79.Research output: Contribution to journal › Article › peer-review
Open Access -
Durvalumab Plus Platinum-Etoposide in Extensive-Stage Small-Cell Lung Cancer: Outcomes in Age, Sex, and Platinum Subgroups From the Phase 3 CASPIAN Study
Reinmuth, N., Goldman, J. W., Chen, Y., Hotta, K., Trukhin, D., Statsenko, G., Hochmair, M., Özgüroğlu, M., Ji, J. H., Garassino, M. C., Poltoratskiy, A., Verderame, F., Havel, L., Bondarenko, I., Losonczy, G., Conev, N., Kummer, S., Mann, H., Chugh, P. & Dalvi, T. & 1 others, , Dec 2025, In: Clinical Lung Cancer. 26, 8, p. 626-641 16 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus) -
Efficacy and safety of cancer vaccine therapy in malignant melanoma: a systematic review
Seta, T., Nakamura, S., Oura, M., Yokoyama, K., Nishikawa, Y., Hoshino, N., Ninomiya, K., Shimoi, T., Hotta, K. & Nakayama, T., Jun 2025, In: International Journal of Clinical Oncology. 30, 6, p. 1080-1097 18 p.Research output: Contribution to journal › Review article › peer-review
2 Link opens in a new tab Citations (Scopus)